Importantly, the role of PGRN as a biomarker for AD has been considered due to its relationship to neuroinflammation [172], where CSF PGRN levels have been described to increase and to be associated with an increase in inflammatory markers in tau-neurodegenerative (TN) + patients [173]. Here, GRN is linked to Alzheimer disease.